The Drugs Controller General of India has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress syndrome. Drugs...
World Health Organization (WHO) has set up an independent panel to review its handling of the COVID-19 pandemic and the response by governments. The...
Given the rapid increase in COVID-19 cases in the country, the Insurance Regulatory and Development Authority of India, IRDAI, has allowed 30 general and health...
Two more COVID-19 patients, including a young woman from Anantnag died on Saturday, taking the total number of novel Coronavirus deaths in J&K to 162....